Sonova (OTCMKTS:SONVY - Get Free Report) was downgraded by investment analysts at Hsbc Global Res from a "strong-buy" rating to a "hold" rating in a research note issued to investors on Wednesday,Zacks.com reports.
Separately, HSBC downgraded Sonova from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".
View Our Latest Stock Report on Sonova
Sonova Price Performance
Shares of Sonova stock traded down $0.58 during trading on Wednesday, hitting $63.64. The company's stock had a trading volume of 9,157 shares, compared to its average volume of 20,118. Sonova has a 52 week low of $52.83 and a 52 week high of $77.56. The stock has a 50-day moving average price of $60.29 and a two-hundred day moving average price of $64.37. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.82 and a current ratio of 1.21.
Sonova Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Featured Stories

Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.